TissueCypher technology provides quantitative analysis of epithelial and stromal immunofluorescent markers expression (p16, AMACR, p53, CD68, COX‐2, CD45RO, HIF1a, HER2/neu and K20) in biopsy specimens with BE. The gene discussed is TP53; the disease is Barrett esophagus.